IP Stars

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector

Showing 81 - 90 of 105 for "Healthcare" with applied filters

News & Analysis

Gulf Capital’s CWB Group acquires Hahn & Hahn, a leading African intellectual property services provider

17 January 2024 by CWB Group

Gulf Capital, one of the largest and most active private equity firms investing from the GCC to Asia, announced today that its portfolio company, the CWB Group, has acquired a majority stake in Hahn & Hahn Group to form an unrivalled super-regional firm servicing and managing intellectual property portfolios of global clients across the Middle East, Africa, Eastern Europe, and Central Asia.

News & Analysis

The uncertainty about uncertainty – the new ground of sufficiency in Singapore

13 June 2023 by Drew & Napier

Tony Yeo, Meryl Koh and Javier Yeo of Drew & Napier analyse the Singapore Court of Appeal’s decision in IIa Technologies Pte Ltd v Element Six Technologies Limited [2023] SGCA 5 (“IIa v E6”)
News & Analysis

A trend in appeals the Indian Registrar of Trademarks

09 May 2023 by LexOrbis

Manisha Singh and Ritika Agarwal of LexOrbis analyse recent rulings by the High Court of Delhi in appeals against decisions by the Registrar of Trademarks
News & Analysis

Skinny label in Brazil: Drug authority seeking to implement new regulations

29 March 2023 by Roberto Rodrigues Pinho and Ricardo Campello (Licks Attorneys)

Roberto Rodrigues Pinho and Ricardo Campello of Licks Attorneys analyses Brazil's legislation and regulation concerning skinny labelling
News & Analysis

Patenting antibody-related inventions in Brazil

11 January 2023 by Rob Rodrigues, Danielle Altomari, Priscila Figueiredo, Ivan Domith

The healthcare sector in Brazil is one of the most important in the world in view of the size of the population (+220 million people) and the availability of a universal public healthcare system. The action of antibodies as therapeutic agents may involve processes of neutralization, opsonization and activation of immune complement system, transforming them into a progressively desirable tool in medicine. In view of this, the interaction between IP and these innovative therapies deserves special attention.
News & Analysis

EPO data: Detergents patent analysis

28 January 2022 by Haseltine Lake Kempner

David Hammond of Haseltine Lake Kempner analyses EPO filings and proceedings data relating to detergents, including the top patentees and opponents
News & Analysis

EPO data: Foodstuffs patent analysis

10 December 2021 by Haseltine Lake Kempner

David Hammond of Haseltine Lake Kempner analyses EPO filings and proceedings data relating to foodstuffs, including plant-based meat and dairy substitutes
News & Analysis

Patents in India and access to medicines during COVID times

01 September 2021 by Manisha Singh and Pankaj Musyuni

Manisha Singh and Pankaj Musyuni of LexOrbis discuss how patent rights are impeding access to medicines and what can be done to minimise the damage caused by COVID-19
News & Analysis

China’s drug-patent linkage system has landed

16 June 2021 by Lili Wu, Ying Li, Yulian Hu and Linlin Zhang

Lili Wu, Ying Li, Yulian Hu and Linlin Zhang of Han Kun Law Offices explain how China’s drug-patent linkage system promotes and encourages innovation and development of the pharmaceutical industry
News & Analysis
Image

The latest news on mRNA patent cases

14 October 2022 by Kingsley Egbuonu

Read about some of the IP disputes concerning mRNA COVID-19 vaccines and the law firms involved
Load more